D
Dale C. Snover
Researcher at University of Minnesota
Publications - 160
Citations - 20700
Dale C. Snover is an academic researcher from University of Minnesota. The author has contributed to research in topics: Adenoma & Colonoscopy. The author has an hindex of 53, co-authored 156 publications receiving 19645 citations. Previous affiliations of Dale C. Snover include Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Jack S. Mandel,John H. Bond,Timothy R. Church,Dale C. Snover,Bradley Gm,Leonard M. Schuman,Fred Ederer +6 more
TL;DR: Cutting mortality in the annually screened group was accompanied by improved survival in those with colorectal cancer and a shift to detection at an earlier stage of cancer.
Journal ArticleDOI
The effect of fecal occult-blood screening on the incidence of colorectal cancer.
Jack S. Mandel,Timothy R. Church,John H. Bond,Fred Ederer,Mindy S. Geisser,Steven J. Mongin,Dale C. Snover,Leonard M. Schuman +7 more
TL;DR: The use of either annual or biennial fecal occult-blood testing significantly reduces the incidence of colorectal cancer.
Journal ArticleDOI
A randomized trial of aspirin to prevent colorectal adenomas
John A. Baron,Bernard F. Cole,Robert S. Sandler,Robert W. Haile,Dennis J. Ahnen,Dennis J. Ahnen,Robert S. Bresalier,Gail McKeown-Eyssen,Robert W. Summers,Richard I. Rothstein,Carol A. Burke,Dale C. Snover,Timothy R. Church,John I. Allen,Michael L. Beach,Gerald J. Beck,John H. Bond,John H. Bond,Tim Byers,E. Robert Greenberg,Jack S. Mandel,Norman E. Marcon,Leila A. Mott,Loretta H. Pearson,Fred Saibil,Rosalind U. van Stolk +25 more
TL;DR: Low-dose aspirin has a moderate chemopreventive effect on adenomas in the large bowel, using generalized linear models to compute risk ratios and 95 percent confidence intervals.
Journal ArticleDOI
Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel
Douglas K. Rex,Dennis J. Ahnen,John A. Baron,Kenneth P. Batts,Carol A. Burke,Randall W. Burt,John R. Goldblum,Jose G. Guillem,Charles J. Kahi,Matthew F. Kalady,Michael J. O'Brien,Robert D. Odze,Shuji Ogino,Susan Parry,Susan Parry,Dale C. Snover,Emina Torlakovic,Paul E. Wise,Joanne P. Young,James M. Church +19 more
TL;DR: It is recommended that all serrated lesions proximal to the sigmoid colon and allserrated lesions in the rectosigmoid >5 mm in size, be completely removed.
Journal ArticleDOI
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
Bernard F. Cole,John A. Baron,Robert S. Sandler,Robert W. Haile,Dennis J. Ahnen,Robert S. Bresalier,Gail McKeown-Eyssen,Robert W. Summers,Richard I. Rothstein,Carol A. Burke,Dale C. Snover,Timothy R. Church,John I. Allen,Douglas J. Robertson,Gerald J. Beck,John H. Bond,Tim Byers,Jack S. Mandel,Leila A. Mott,Loretta H. Pearson,Elizabeth L. Barry,Judy R. Rees,Norman E. Marcon,Fred Saibil,Per Magne Ueland,E. Robert Greenberg +25 more
TL;DR: In this paper, the safety and efficacy of folic acid supplements for preventing colorectal adenomas were evaluated in a randomized clinical trial. But, the results showed that folic acids at 1 mg/d did not reduce coloreCTal adnoma risk.